No Detail Found!

Outcome of first relapse of Hodgkin lymphoma: single institution experience

Author(s)
Najma Shaheen Department of Pediatric Oncology, Shakut Khanum Cancer Hospital and Research Center,Lahore,Pakistan
Ata Ur Rehman Maaz Department of Pediatric Hematology, Sidra Medical and Research Center,Doha,Qatar
Muhammad Saghir Khan Department of Pediatric Hematology Division, Tawam Hospital, Alain, Abu Dhabi, UAE
Abstract
Objective: To determine outcome of rfist relapse of Hodgkin lymphoma with standard dose chemotherapy, and to identify the prognostic factors predicting survival outcome in paediatric patients. Method: The retrospective study was conducted at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, and comprised data of Hodgkin lymphoma patients who relapsed at least 3 months after the completion of initial treatment from January 2001 to December 2010. Probabilities of overall survival, event-free survival and cumulative incidence were calculated. Data was analysed using SPSS 21. Results: Of the 43 patients, 31(72%) were males and 12(29%) were females. Mean age at relapse was 11±3.3 years (range: 4-17 years). In 31(72%) patients, early post-operative intraperitoneal chemotherapy was employed. Median follow-up of the cohort was 62 months (interquartile range: 4-187 months). Overall survival and event-free survival at 10 years was 23(54%) and 15(35%) respectively. On univariate analysis, initial disease stage (p=0.021), stage at relapse (p=0.003), treatment protocol (p=0.005), treatment responsiveness at initial two cycles of salvage chemotherapy (p=0.002) and at the end of treatment assessment (p=0.0009) were statistically signicfiant factors. Multivariate cox regression analysis revealed disease stage at relapse (p=0.004), chemotherapy regimen (p=0.025) and end-of-treatment disease evaluation (p=0.005) as the signicfiant variables. Conclusion: Improved outcome with early post-operative intraperitoneal chemotherapy regimen was noted for Hodgkin lymphoma patients who had disease-free interval >2 years.
Publication Details
Page(s) 883-888
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 71, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
2021), Mediastinal mass, B symptoms, Stage 4, Chemo-sensitivity, Relapse Hodgkin lymphoma. (JPMA 71: 883
0

Citations

0

Downloads

139

Views